Steve Horvath's Clock vs. Morgan Levine's PhenoAge: Which Test Should You Take?

For anyone looking to understand their biological age beyond their chronological years, the concepts of epigenetic and phenotypic clocks have become central. Among the most recognized names in this field are Steve Horvath and Morgan Levine, both pioneers in developing methods to measure biological age. This article will compare two prominent biological age tests: the original Horvath epigenetic clock and Morgan Levine’s PhenoAge, helping you understand their differences, strengths, and which might be more suitable for your interests.

The Association Between Epigenetic Clocks and Physical Function

Biological age, often distinct from chronological age, reflects the functional and cellular health of an individual. It’s a more dynamic measure, influenced by genetics, lifestyle, and environment. Epigenetic clocks, like the Horvath clock, assess biological age by analyzing methylation patterns on DNA. These patterns change predictably with age, acting as molecular markers.

The Horvath clock, introduced in 2013, was groundbreaking. It was the first “pan-tissue” clock, meaning it could estimate age from almost any tissue type in the body. This broad applicability made it a powerful tool for research, allowing scientists to study aging across different organs and cell types. The clock analyzes methylation at 353 specific CpG sites across the genome. The underlying idea is that as we age, certain genes get methylated or demethylated in a consistent way, providing a molecular fingerprint of age.

While the Horvath clock demonstrated a strong correlation with chronological age, its direct association with physical function and health outcomes was initially less clear. Its primary strength lay in its robust prediction of chronological age and its utility in understanding the fundamental mechanisms of epigenetic aging. For instance, researchers could use it to see if certain interventions or diseases accelerated or decelerated this epigenetic aging process in various tissues. However, for an individual seeking to understand their current health status or risk for age-related diseases, a clock more directly tied to health markers might be more informative.

Epigenetic Aging Clocks Compared: Which One Predicts Health Outcomes Better?

The field of epigenetic aging has evolved significantly since the Horvath clock’s inception. While Horvath’s original clock was a landmark in establishing the concept of epigenetic age, subsequent clocks aimed to improve its predictive power for health and lifespan. This is where the distinction between “first-generation” and “second-generation” clocks becomes important.

The Horvath clock is generally considered a first-generation epigenetic clock. It was developed to predict chronological age as accurately as possible. Its ability to predict all-cause mortality or specific health conditions, while present, was often secondary to its chronological age prediction.

Morgan Levine’s PhenoAge, developed in 2018, represents a significant step forward, often categorized as a second-generation clock. Instead of solely relying on chronological age for its development, PhenoAge was trained using a composite “phenotypic age” based on nine clinical biomarkers commonly found in routine blood tests. These biomarkers include albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean corpuscular volume, red blood cell distribution width, alkaline phosphatase, and white blood cell count. The clock then identifies methylation sites that best predict this phenotypic age.

This fundamental difference in training makes PhenoAge inherently more attuned to health outcomes. Because it was designed to reflect a measure of physiological health, PhenoAge tends to be a stronger predictor of healthspan, frailty, and all-cause mortality than the original Horvath clock. For example, a person whose PhenoAge is significantly higher than their chronological age might have a higher risk of developing age-related diseases or experiencing a shorter lifespan, even if their Horvath epigenetic age aligns closely with their chronological age.

The utility of each clock depends on the specific question being asked. If the goal is to understand the basic molecular processes of aging across different tissues, the Horvath clock remains highly valuable. If the aim is to assess an individual’s current physiological health status and predict future health risks, PhenoAge often provides more relevant insights.

An Unbiased Comparison of 14 Epigenetic Clocks in Relation to Health

The proliferation of epigenetic clocks has led to the need for comparative studies to understand their relative strengths and weaknesses. Researchers have developed numerous clocks, each with slightly different training data, CpG sites, and predictive capabilities. These studies often evaluate clocks based on how well they predict chronological age, all-cause mortality, and various age-related health conditions.

When comparing the Horvath clock and PhenoAge in such comprehensive analyses, consistent patterns emerge:

• Horvath Clock:

  • Strengths: Excellent prediction of chronological age across diverse tissues. Robust and widely applicable for fundamental research into epigenetic aging mechanisms. Generally stable across different populations.
  • Limitations: While it correlates with health outcomes, it is not optimized for their prediction. A discrepancy between Horvath epigenetic age and chronological age might indicate accelerated aging, but it doesn’t directly pinpoint why or how this translates to specific health risks as effectively as later clocks.

• PhenoAge:

  • Strengths: Superior prediction of all-cause mortality, healthspan, frailty, and various age-related diseases. More directly reflective of an individual’s current health status. The “age acceleration” calculated by PhenoAge (PhenoAge minus chronological age) is a powerful predictor of adverse health outcomes.
  • Limitations: Primarily developed for blood samples, its applicability to other tissues is not as universal as the Horvath clock. It relies on the accuracy of the clinical biomarkers used in its training, which can vary.

Consider a scenario: Two individuals, both 50 years old chronologically.

• Individual A: Has a Horvath epigenetic age of 50 and a PhenoAge of 50. This suggests their epigenetic aging is in line with their chronological age, and their physiological health markers are consistent with their age.
• Individual B: Has a Horvath epigenetic age of 50 but a PhenoAge of 60. This individual’s epigenetic age might align with their chronological age, but their physiological health indicators, as captured by PhenoAge, suggest an accelerated biological aging process that could lead to higher health risks.

This distinction highlights PhenoAge’s advantage for individuals interested in actionable health insights.

Choosing Epigenetic Clock Models: Horvath, Hannum, and Beyond

Beyond Horvath and PhenoAge, other significant epigenetic clocks exist, each with its own focus. The Hannum clock, for example, was developed around the same time as Horvath’s but specifically for blood samples, predicting chronological age based on 71 CpG sites. While also a first-generation clock, it offered a more targeted approach for blood-based studies.

The evolution of epigenetic clocks can be broadly categorized:

• First-Generation Clocks (e.g., Horvath, Hannum): Primarily designed to predict chronological age. Excellent for understanding the fundamental relationship between methylation and time.
• Second-Generation Clocks (e.g., PhenoAge, GrimAge): Designed to predict health-related outcomes, including morbidity and mortality. These clocks incorporate insights from clinical data or biomarkers into their training.
• Third-Generation Clocks (e.g., DunedinPoAm): Focus on the rate of aging or “pace of aging” rather than just a static age estimate. These often use longitudinal data to track changes over time and are considered even more dynamic and predictive of health trajectories.

When deciding which clock is “best,” it’s crucial to align the clock with the specific goal.

For an individual seeking to understand their personal health trajectory, PhenoAge or even newer clocks like GrimAge (which predicts mortality and disease risk by modeling levels of plasma proteins and smoking pack-years) and DunedinPoAm (which measures the pace of aging) are generally considered more informative than the original Horvath clock.

Epigenetic Clock: The Science Behind Measuring Aging

The science behind epigenetic clocks revolves around DNA methylation, a process where a methyl group is added to a DNA base, typically cytosine. These methylation tags don’t change the underlying DNA sequence but can alter gene expression. Importantly, methylation patterns are influenced by both genetics and environmental factors, and they change systematically throughout life.

The development of an epigenetic clock involves several key steps:

1. Sample Collection: DNA is extracted from biological samples (e.g., blood, saliva, tissue).
2. Methylation Profiling: The methylation status of hundreds or thousands of specific CpG sites (cytosine-phosphate-guanine dinucleotides) across the genome is measured using technologies like Illumina BeadArrays.
3. Algorithm Training: A machine learning algorithm (often a penalized regression model) is trained on a large dataset of individuals with known chronological ages (for first-generation clocks) or known health biomarker data (for second-generation clocks like PhenoAge). The algorithm identifies the combination of CpG sites and their methylation levels that best predict the target variable (age or phenotypic age).
4. Validation: The trained clock is then tested on independent datasets to ensure its accuracy and generalizability.

The output of an epigenetic clock is typically an “epigenetic age” or “biological age.” This value can then be compared to an individual’s chronological age. The difference, often called “age acceleration” or “age deceleration,” is what researchers and individuals often focus on. Positive age acceleration suggests an individual’s biological age is older than their chronological age, potentially indicating accelerated aging. Conversely, negative age acceleration suggests a younger biological age.

The utility of these clocks extends beyond simply knowing a number. They are powerful tools for:

• Research: Identifying environmental factors, lifestyle choices, or genetic variants that influence the aging process.
• Intervention Studies: Assessing the impact of anti-aging interventions, dietary changes, or pharmaceutical compounds on biological age.
• Personalized Medicine (Future): Potentially guiding clinical decisions and personalized health recommendations.

However, it’s important to remember that these clocks are statistical predictors. They do not represent a single, universally agreed-upon “true” biological age but rather a highly accurate estimate based on specific molecular markers.

Epigenetic Clocks for Clinical Trials and Personalized Health

The application of epigenetic clocks is rapidly expanding, particularly in clinical trials and the realm of personalized health. Their ability to provide an objective, quantifiable measure of biological aging makes them invaluable for evaluating interventions aimed at improving healthspan or longevity.

Clinical Trials

In clinical trials, epigenetic clocks can serve several critical functions:

• Biomarker for Intervention Efficacy: Researchers can use clocks to assess whether a new drug, dietary regimen, or lifestyle intervention effectively slows down or reverses biological aging. For example, a trial for a novel anti-aging compound might measure participants’ epigenetic age before and after treatment to see if there’s a significant reduction in age acceleration.
• Patient Stratification: Clocks can help identify individuals who might be at higher risk for age-related diseases or who might respond differently to interventions based on their biological age.
• Prognostic Indicator: In trials for specific diseases, an individual’s epigenetic age might provide additional prognostic information beyond traditional clinical markers.
• Understanding Disease Mechanisms: By correlating epigenetic age acceleration with disease progression, researchers can gain insights into the role of accelerated aging in various pathologies.

For these applications, second-generation clocks like PhenoAge and GrimAge are often preferred due to their stronger association with health outcomes and mortality. They offer a more direct measure of the “health” aspect of aging, which is often the target of clinical interventions.

Personalized Health

For individuals, the decision to take an epigenetic age test is often driven by a desire for self-knowledge and a proactive approach to health. While these tests are primarily used in research settings, direct-to-consumer options are becoming more available.

If you are considering such a test, here’s what to keep in mind:

• Understand the “Why”: What do you hope to gain from the information? Are you curious about your general biological age (Horvath) or more interested in your health trajectory and disease risk (PhenoAge)?
• Context is Key: A single epigenetic age number is a snapshot. It’s most meaningful when considered alongside your lifestyle, medical history, and other health metrics.
• Actionability: While a high PhenoAge might indicate higher health risks, the actionable steps are generally those already recommended for good health: balanced diet, regular exercise, stress management, adequate sleep, and avoiding smoking and excessive alcohol. The test doesn’t provide a magic bullet but can serve as a motivator.
• Cost and Reliability: Direct-to-consumer tests can be expensive. Research the company’s scientific backing, lab accreditation, and interpretation services.

Ultimately, both Horvath’s original clock and Levine’s PhenoAge are powerful scientific tools. For personal health insights, PhenoAge often provides a more directly relevant measure of physiological aging and its associated risks, making it generally more aligned with the goals of someone seeking to understand and potentially improve their healthspan.

FAQ

Is the Horvath test legitimate?

Yes, the Horvath test is legitimate. It was developed by Dr. Steve Horvath, a leading researcher in the field of epigenetics, and published in a peer-reviewed scientific journal (Genome Biology in 2013). It is widely used in scientific research to study the mechanisms of aging and the effects of various factors on biological age. Its primary strength lies in its ability to accurately predict chronological age across almost all human tissues. However, it’s important to understand that its legitimacy is as a scientific tool for measuring epigenetic age, not necessarily as a direct diagnostic tool for disease in a clinical setting.

What is the PhenoAge and GrimAge clock?

PhenoAge is an epigenetic clock developed by Morgan Levine and colleagues. Unlike first-generation clocks that primarily predict chronological age, PhenoAge was trained using a combination of chronological age and nine routine clinical biomarkers from blood tests (e.g., albumin, glucose, C-reactive protein). This makes PhenoAge a stronger predictor of healthspan, frailty, and all-cause mortality, reflecting an individual’s physiological health rather than just their chronological age.

GrimAge is another advanced epigenetic clock, also developed by Steve Horvath and colleagues, that represents a further step in predicting health outcomes. GrimAge was trained to predict time to death, coronary heart disease, cancer, and other age-related morbidities. It incorporates methylation markers that correlate with smoking pack-years and plasma protein levels (e.g., plasminogen activator inhibitor 1, cystatin C, growth differentiation factor 15). GrimAge is often considered one of the most powerful epigenetic predictors of all-cause mortality and disease risk.

How much does a Horvath test cost?

The cost of an epigenetic age test, whether it uses the Horvath clock, PhenoAge, or other algorithms, can vary significantly. As of late 2023/early 2024, direct-to-consumer epigenetic age tests typically range from approximately $250 to $500 or more. These prices often include the sample collection kit (usually saliva or blood spot), laboratory analysis, and a report detailing your biological age and sometimes other relevant metrics. The specific clock used (Horvath, PhenoAge, GrimAge, etc.) might influence the price, as some tests offer analysis by multiple algorithms.

Conclusion

When deciding between Steve Horvath’s original epigenetic clock and Morgan Levine’s PhenoAge, the choice hinges on your primary interest. If your curiosity lies in understanding the foundational epigenetic changes that occur with chronological aging across various tissues, the Horvath clock provides robust insights. It remains a cornerstone for basic research into the mechanisms of aging.

However, if your goal is to gain a more direct understanding of your current physiological health, predict your risk for age-related diseases, or assess potential changes in your health trajectory due to lifestyle or interventions, PhenoAge is generally the more relevant and informative test. Its development explicitly incorporated clinical biomarkers, making its output more closely tied to healthspan and mortality.

For most individuals seeking actionable information about their personal health and aging process, second-generation clocks like PhenoAge (and even newer ones like GrimAge or DunedinPoAm) offer a more comprehensive and predictive picture than the original Horvath clock. Ultimately, these tests are powerful tools for self-exploration and scientific research, providing valuable data points to consider alongside conventional health assessments.